0.07
-0.0977(-60.05%)
Currency In USD
| Previous Close | 0.16 |
| Open | 0.09 |
| Day High | 0.09 |
| Day Low | 0.06 |
| 52-Week High | 11 |
| 52-Week Low | 0.06 |
| Volume | 11.02M |
| Average Volume | 1.65M |
| Market Cap | 288,798 |
| PE | -0.01 |
| EPS | -5.5 |
| Moving Average 50 Days | 1.19 |
| Moving Average 200 Days | 2.43 |
| Change | -0.1 |
If you invested $1000 in TFF Pharmaceuticals, Inc. (TFFP) since IPO date, it would be worth $0.51 as of December 21, 2024 at a share price of $0.065. Whereas If you bought $1000 worth of TFF Pharmaceuticals, Inc. (TFFP) shares 3 years ago, it would be worth $0.3 as of December 21, 2024 at a share price of $0.065.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
TFF Pharmaceuticals Announces It Will Wind Down Operations
GlobeNewswire Inc.
Nov 14, 2024 9:15 PM GMT
FORT WORTH, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) today announced that the Company has terminated its employees and will wind down its operations. This decision was made at a special meeting of the board
TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery
GlobeNewswire Inc.
Sep 26, 2024 11:00 AM GMT
Newly published data in the Journal of Drug Delivery Science and Technology demonstrate more uniform drug distribution in the lung compared with other technologiesFORT WORTH, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasda
TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID
GlobeNewswire Inc.
Sep 11, 2024 11:00 AM GMT
Partnership funded by BARDA and other US government agencies TFF formulation may provide flexibility of delivery and improve storage and distribution conditions FORT WORTH, Texas, Sept. 11, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq:
Data not available